Product: | DL-Carnitine-d9 hydrochloride | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D2156 | ||||||||
CAS Number: | 1219386-75-0 | ||||||||
Pricing: |
|
||||||||
Formula: | C7D9H7ClNO3 | ||||||||
Molecular Weight: | 206.72 | ||||||||
Structure: | |||||||||
Appearance: | Solid | ||||||||
Category: | Reference Standards for Inborn Errors | ||||||||
Stability: | Stable under recommended storage conditions. | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Steiber A, Kerner J, Hoppel C., Carnitine: a nutritional, biosynthetic, and functional perspective. Mol. Aspects Med., 2004, 25 (5–6): 455–73.; A. J. Liedtke, S. H. Nellis, L. F. Whitesell and C. Q. Mahar, Metabolic and mechanical effects using L- and D-carnitine in working swine hearts. Heart and Circulatory Physiology, 1982, 243 (5): H691–H697.; Benvenga S, Amato A, Calvani M, Trimarchi F., Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci, 2004, 1033: 158–167. |
||||||||
MSDS: | |||||||||
Description: | A labeled quartenary ammonium compound. Used for the transport of fatty acids from the intermembrane space into the mitochondrial matrix in eukaryotic cells during the breakdown of lipids for the generation of metabolic energy. Lowers the risk of mortality and arrhythmias after an acute myocardial infarction. Decreases bone turnover and increases bone mineral density. May also be used to treat hyperthyroidism. |